The nanogels were conjugated with the VNAR CV0-43, as this antibody can recognize the carcinoembryonic antigen (CEA) present in colon cancer cells [10] Nanogel preparation for bioconjugation and VNAR anchoring is depicted in Scheme 1. Here, CEACAM5 is linked to malignant colon neoplasm.